Novo Nordisk A/S (NVO)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$142.80

Buy

$142.98

arrow-down$-2.44 (-1.68%)

Prices updated at 03 Jul 2024, 00:58 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company’s business segments include, diabetes and obesity care, and biopharmaceuticals.
S&P 500
arrow-up0.62%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
145.42
triangle-d
arrow-down
-3.73 (-2.56%)
triangle-d
Today open
141.69
triangle-d
arrow-up
1.29 (+0.91%)
triangle-d
Today, 00:58:05 BST
142.98
triangle-d
$143.37 - $139.03
$148.15 - $75.56
0.96
643,999.31m
50.74
-
6,594,458
45.49
5,247,441.26
0.61
4,510.00m
US6701002056
19.91
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.